Features of the composition of hospitalized patients with benign prostatic hyperplasia in the aspect of the outpatient stage of medical care

С. П. Пасєчніков, Я. М. Клименко, Ахмед Моаллім Абдулфатах, Я. М. Мельничук


The objective: analysis of data on the current composition of patients with benign prostatic hyperplasia (BPH) hospitalized for surgical care.

Materials and methods. The study involved 266 patients with BPH, who underwent transurethral resection of the prostate in the profile department of the Aleksandrovsky Clinical Hospital in 2015–2016 in order to assess the general condition of the patients at the time of hospitalization and to identify the problematic issues of providing medical care in ambulatory-polyclinic conditions.

Results. It was found out that the significant majority was hospitalized urgently (53,0%), more often in the winter-autumn period of the year (60,4%), the age of which differs be a large percentage of patients under 60 years (12,8% versus 10,4% with a planned one). Among them, men were about 70 years old, 10% were newly diagnosed cases, half of them had symptoms of lower urinary tract (LUT) during 5 years at the time of going to the doctor. With rare exceptions, patients were treated conservatively, took α -adrenoblockers (2/3 to 5 years, 1/3 – 5 to 10 and more years). In 27,8% of patients, there were repeated cases of acute urinary retention (AUR), twice as often among urgently hospitalized ones. Practically all the course of the diseases was complicated by concomitant pathology (1227 nosological units of diseases of different organs and systems). There number increases with age: one patient at 44 to 59 years old had in average 3.0; 60–69 – 4.4; 70–79 – 5.2; ≥80 years – 5.6. Cardiovascular diseases prevail, in every forth there is chronic inflammatory, metabolic syndrome (DM, obesity).

Conclusion.The findings confirmed a clear relationship between the volume of the prostate and intravesical prostatic protrusion (IPP) – r=0.33, which was more pronounced with a maximum urination rate (r=0.59) with the residual volume. It was revealed that with the increase of IPP the volume of residual urine decreases with a simultaneous deterioration of the quality of life and an increase in the LUT symptomatology. However, they do not depend on the volume of the prostate.


benign prostatic hyperplasia; types of hospitalization; α-adrenoblockers; accompanying pathology; results of the survey


Аполихин О.И., Сивков А.В., Яненко Э.К., Катибов М.И., Золотухин О.В. и др. Частота выявления острой задержки мочи как индикатора качества оказания медицинской помощи пациентам с аденомой предстательной железы // Урология. – 2016;2:43–48.

Братчиков О.И., Шумакова Е.А., Хмарук А.П. [и др.]. Инфекционно-воспалительные осложнения простатэктомии у больных аденомой предстательной железы // Научные ведомости Белгородского государственного университета. Серия «Медицина. Фармация» – 2011;4(99):13–21.

Возіанов С.О., Шуляк О.В., Гжегоцький М.Р. та ін. Передміхурова залоза та її доброякісна гіперплазія. – Львів, 2004:343.

Гаджиева Ж.К. Нарушения мочеиспускания: Руководство / Под ред. Ю.Г. Аляева. – М.: РЭОТАР-Медиа, 2010:307.

Лопаткин Н.А. Доброкачественная гиперплазия предстательной железы / Под ред. Н.А. Лопаткина. – М.: Медицина, 1999:216.

Лоран О.Б., Вишневский Е.Л., Вишневский А.Е. Лечение расстройств мочеиспускания у больных гиперплазией простаты α-адреноблокаторами. – М., 1998.

Пасєчніков С.П., Возіанов С.О., Павлова Л.П. та ін. Доброякісна гіперплазія передміхурової залози (епідеміологія, удосконалення системи медичної допомоги) // Урологія. 2000;4:27–33.

Ситдыкова М.Э., Цыплаков Д.Э., Ситдыков Э.Н., Нуртдинов А.Р. Обоснование сроков медикаментозной терапии больных с доброкачественной гиперплазией предстательной железы (клинико-морфологическое исследование) // Урология. – 2017;2:42–47.

Abrams P., Chapple C., Khouri S. et al. Evaluation and treatment of lower urinary symptoms in older men // J. Urol. – 2009;181:1779–1787.

Blanchard K., Hananel A., Rutchik S. et al. Transurethral resection of the prostate: failure patterns and surgical outcomes in patients with symptoms refractory to alpha-antagonists // South Med J. – 2000 Dec; 93(12): 1192–6.

Chapple C. et al. Systematic review of therapy of men with overactive bladder // Can. Urol. Assoc. J. – 2011; 5(2):143–145.

Flanigan RC, Reda DJ, Wasson JH. et al. 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperoplasia: a Department of Veterans Affairs cooperative study // J Urol. – 1998 Jul; 160(1): 12–6; discussion 16–7.

Kim TH et al. Comparison of the efficacy and safety of tolterodine 2 mg and 4 mg combined with an alphablocker in men with lower urinary tract symptoms (LUTS) and overactive bladder: a randomized controlled trial // BJU Int. – 2016;117:307–315.

Management of non-neurogenic male lower urinary tract symptoms (LUTS) – update March 2017

Mangera A, Ch.Chapple. Научно обоснованное обновление рекомендаций по обследованию и лечению мужчин с симптомами нижних мочевыводящих путей // Урология.– 2015;2:94–101.

Soga N, Sugimura Y. Analysis of changes in lower urinary tract symptoms with aging // Nippon Hinyokika Gakkai Zasshi. – 2004:766–72. (Japanese).

Wang W, Bergh А, Damber JE. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium // Prostate. 2004.61(1):60–72.

Yu-Hsiang Lin, Chen-Pang Hou, Tien-Hsing Chen et al. Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction. BMC Geriatr. 2018; 18: 15. Published online 2018 Jan 16.

Copyright (c) 2020 С. П. Пасєчніков, Я. М. Клименко, Ахмед Моаллім Абдулфатах, Я. М. Мельничук

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

ISSN 2412-5547 (Online), ISSN 2307-5090 (Print)